For research use only. Not for therapeutic Use.
Pinatuzumab Vedotin (RG-7593, DCDT2980S, DCDT-2989S), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker.
| Catalog Number | I047419 |
| Purity | ≥95% |
| Reference | [1] Advani RH, et al. Clin Cancer Res. 2017 Mar 1;23(5):1167-1176. |
